electroCore (ECOR) vs Stereotaxis (STXS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
electroCore (ECOR) has outperformed Stereotaxis (STXS) over the past year, gaining 96.4% versus a loss of 64.5%. Over five years, ECOR leads with a -35.0% price change compared with -80.9% for STXS. Stereotaxis is the larger company by market cap ($113.2 million vs $87.6 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ECOR | STXS |
|---|---|---|
| Share price | $9.72 | $1.13 |
| Market cap | $87.63M | $113.23M |
| 1-day change | -2.02% | -1.74% |
| YTD return | +116.72% | -50.87% |
| 1-year return | +96.36% | -64.47% |
| 5-year return | -35.01% | -80.94% |
| EPS (TTM) | $-1.65 | $-0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.70 | $3.59 |
| 52-week low | $4.41 | $1.12 |
| Distance from 52-week high | -23.46% | -68.52% |
| Average volume | 82.66K | 817.38K |
| Shares outstanding | 9.02M | 100.20M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ECOR has outperformed STXS by 160.8 percentage points over the past year.
ECOR vs STXS FAQ
Which is bigger, electroCore or Stereotaxis?
Stereotaxis (STXS) is larger, with a market capitalization of $113.23M compared with $87.63M for electroCore (ECOR).
Which stock has performed better over the past year, ECOR or STXS?
ECOR returned +96.36% over the past 12 months, compared with -64.47% for STXS (price return, excluding dividends). Past performance does not predict future results.
Are electroCore and Stereotaxis in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.